证券记录 · 已归档季度
CI
Cigna Corporation · Healthcare · Medical - Healthcare Plans
20被追踪持有人
n/aΔ持有人
38.82M持有股份
$12.83B报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 466.88K | $125.61M | +1 | n/a |
| Q2 2026 | 179 | 0 | 199.67M | $55.07B | +4 | −3 |
| Q1 2026 | 181 | +2 | 199.25M | $53.08B | +3 | −2 |
| Q4 2025 | 178 | +1 | 211.33M | $58.16B | +2 | n/a |
| Q3 2025 | 27 | 0 | 123.40M | $35.56B | n/a | −1 |
| Q2 2025 | 25 | +2 | 110.22M | $36.42B | +2 | n/a |
| Q1 2025 | 20 | +1 | 48.70M | $16.02B | +1 | n/a |
| Q4 2024 | 19 | -1 | 48.42M | $13.37B | n/a | −1 |
| Q3 2024 | 19 | -1 | 37.77M | $13.08B | n/a | −1 |
| Q2 2024 | 20 | n/a | 38.82M | $12.83B | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 12.40M | n/a | $4.10B | 0.5% | n/c | 1 | SEC ↗ ×2 |
| 2 | Dodge & Cox ✦ | 8.85M | n/a | $2.93B | 1.8% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 5.83M | n/a | $1.92B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (被动) | 3.13M | n/a | $1.03B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 2.59M | n/a | $855.60M | 0.8% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.55M | n/a | $510.47M | 0.8% | n/c | 1 | SEC ↗ ×5 |
| 7 | Glenview Capital ✦ | 1.29M | n/a | $427.69M | 9.1% | n/c | 1 | SEC ↗ |
| 8 | Capital World Investors ✦ | 1.19M | n/a | $394.25M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 310.73K | n/a | $102.72M | 0.3% | n/c | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 287.36K | n/a | $94.99M | 0.2% | n/c | 1 | SEC ↗ |
| 11 | Bridgewater Associates ✦ | 282.70K | n/a | $93.45M | 0.5% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 225.72K | n/a | $74.62M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 223.32K | n/a | $73.82M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 14 | Millennium Management ✦ | 219.30K | n/a | $72.49M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 193.00K | n/a | $63.80M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 169.66K | n/a | $56.08M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 43.42K | n/a | $14.35M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 17.82K | n/a | $5.89M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 19 | GAMCO Investors ✦ | 15.98K | n/a | $5.28M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 1.40K | n/a | $464,058 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,635 持有人, 229.05M 股份, $59.07B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 03
Neville Everett
Officer · 617 股 · $175,259
Aug 18
Jones Nicole S
Officer · 2.68K 股 · $748,516
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据